Extraction method of mycobacterium nucleic acid

The cell wall structure of Mycobacterium tuberculosis was destroyed by PBS buffer and protease K, and its nucleic acid was extracted in combination with magnetic beads, which solved the problem of low extraction efficiency in the existing technology, and achieved efficient and stable nucleic acid extraction and automated adaptation. .

CN118979033APending Publication Date: 2024-11-19NANJING PREGENE BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411030259.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The prior art is difficult to effectively extract nucleic acids from Mycobacterium tuberculosis, especially due to its special cell wall structure, which leads to low extraction efficiency, which affects the sensitivity and specificity of molecular detection.

Method used

The samples were liquefied and diluted by PBS buffer, and cell lysed by combining protease K and lysate, and nucleic acid recovery was performed by magnetic beads. The extraction efficiency was improved by grinding and wall-breaking treatment of zirconia beads of different particle sizes.

Benefits of technology

It realizes efficient extraction of mycobacterium nucleic acid, reduces detection cost and operation complexity, improves extraction efficiency and stability of detection results, and adapts to automated detection solutions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979033A_ABST
    Figure CN118979033A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of mycobacteria, in particular to an extraction method of mycobacteria nucleic acid. The invention provides a method for extracting mycobacterium nucleic acid in a sputum sample or an alveolar lavage fluid sample. The method mainly comprises the following steps: (1) liquefying and diluting a sample to be extracted; (2) adding a sample releasing agent, and grinding by using grinding beads; (3) adding protease and a lysate to lyse the ground sample; (4) adding a magnetic bead suspension and a binding solution into the cracked sample; (5) cleaning the magnetic beads by using a first cleaning solution and a second cleaning solution; and (6) eluting by using an eluent to obtain the mycobacterium nucleic acid. The extraction method is simple and efficient, the use of toxic reagents is avoided, the extraction efficiency is improved, the extraction time is shortened, meanwhile, automatic adaptation can be supported, and the extracted product can be used for molecular detection such as PCR, qPCR, dPCR and metagenome sequencing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of mycobacteria, and in particular to a method for extracting mycobacterium nucleic acid. Background Art

[0002] Mycobacterium tuberculosis is a typical pathogen that can invade susceptible organisms through the respiratory tract, digestive tract or skin lesions, causing tuberculosis in multiple tissues and organs, of which pulmonary tuberculosis is the main type of disease. At present, the detection of tuberculosis requires immunological diagnosis, etiological diagnosis and drug sensitivity testing, but the sensitivity and specificity of immunological diagnosis are poor, the etiological diagnosis cycle is long and the sensitivity is poor, and the drug sensitivity test is time-consuming and the results are not satisfactory. Compared with traditional culture methods, the molecular biological detection method of Mycobacterium tuberculosis significantly shortens the detection time and improves the sensitivity and specificity. At the same time, the molecular biological detection method can be used for strain identification and drug resistance gene detection, which is conducive to the rapid diagnosis and timely treatment of tuberculosis.

[0003] However, the sensitivity of molecular detection of Mycobacterium tuberculosis is affected by the efficiency of nucleic acid extraction, and the specificity of detection needs to effectively exclude nontuberculous mycobacteria (NTM). Therefore, molecular detection of Mycobacterium tuberculosis requires effective extraction of nucleic acids of mycobacterial pathogens from clinical samples and identification and detection.

[0004] The extraction of mycobacteria is difficult, mainly because of the special cell wall structure of the outer layer of mycobacterial cells. The mycobacterial cell wall is composed of three covalently linked layers, from the inside to the outside: peptidoglycan layer, arabinogalactan layer and mycobacterial acid layer surrounded by glycolipids non-covalently. The entire cell wall structure is densely interlaced, highly hydrophobic, and has poor fluidity and permeability. It is a natural barrier for mycobacteria to resist external pressure. Therefore, it is necessary to fully destroy the cell wall structure of the outer layer of bacteria in order to fully lyse the bacterial cells and release the genomic nucleic acid.

[0005] With the development of diagnostic technology for upper respiratory tract epidemic diseases, the technology of pathogen molecular detection has received more and more attention and has gradually played a role in the diagnosis and treatment of various infectious diseases. At the same time, the development of automated technology for pathogen nucleic acid extraction has also been rapidly promoted. According to statistics, the market share of domestic automated nucleic acid extractors has far exceeded that of imported equipment. However, most of the current automated nucleic acid extraction schemes are more suitable for pathogens such as viruses and Gram-negative bacteria that are less difficult to extract. For the extraction of nucleic acid from mycobacteria, both the extraction reagents and the adaptation of automated extraction schemes need to be developed independently from other pathogens.

[0006] Therefore, it is of great practical significance to develop an extraction method that is more suitable for mycobacterial nucleic acid, improve extraction efficiency and time, and support the adaptation of automated schemes and subsequent molecular detection. Summary of the invention

[0007] The technical problem to be solved by the present invention is to provide a method for extracting mycobacterium nucleic acid in view of the deficiencies of the prior art.

[0008] The inventive idea of ​​the present invention is: currently most automated nucleic acid extraction schemes are more suitable for pathogens such as viruses and Gram-negative bacteria that are less difficult to extract. For the nucleic acid extraction of mycobacteria, both the extraction reagents and the adaptation of the automated extraction scheme need to be developed independently from other pathogens. Consistent with microorganisms containing cell wall structures such as Gram-positive bacteria and fungi, the extraction of mycobacteria also requires complex sample pre-treatment. After destroying the complex structure of the cell wall through sample pre-treatment, the present invention uses proteinase K and lysis solution to lyse the cells, release genomic nucleic acids, and recover nucleic acids by magnetic bead method. When performing extraction efficiency analysis, the feasibility of automated adaptation can be simultaneously evaluated.

[0009] In order to solve the above technical problems, the technical solution adopted by the present invention is as follows:

[0010] A method for extracting mycobacterium nucleic acid comprises the following steps:

[0011] (1) Liquefaction and dilution: Add PBS buffer to the sample to be extracted and mix well to obtain a liquefied and diluted sample to be extracted;

[0012] (2) grinding: mixing the sample to be extracted after liquefaction and dilution in step (1) with the sample release agent, and then grinding to obtain the supernatant;

[0013] (3) Lysis and binding: adding the lysis solution, magnetic bead suspension and binding solution to the mixed solution after the first incubation obtained in step (2), mixing and centrifuging, and removing the supernatant to obtain magnetic beads with mycobacterial nucleic acid adsorbed on the surface;

[0014] (4) Washing: adding a first washing solution to the magnetic beads of step (3), mixing and centrifuging, and removing the supernatant; then adding a second washing solution, mixing and centrifuging, and removing the supernatant to obtain magnetic beads with impurities removed and mycobacterial nucleic acid adsorbed on the surface;

[0015] (5) Elution: resuspend the magnetic beads in step (4) using the elution solution, incubate, and centrifuge to obtain mycobacterial nucleic acid.

[0016] Wherein, the sample to be extracted is a sputum sample or a bronchoalveolar lavage fluid sample.

[0017] The volume ratio of the sample to be extracted, PBS buffer, sample release agent and lysis solution is: 1-2: 1-4: 0.5-1: 3-6.

[0018] Preferably, in some embodiments of the present invention, the volume ratio of the sample to be extracted, PBS buffer, sample release agent and lysis solution is 2:1:1:6 (alveolar lavage fluid sample) or 1:2:1:6 (sputum sample).

[0019] The extraction of pathogenic mycobacterium nucleic acid from sputum and bronchoalveolar lavage fluid requires special pre-treatment, and generally requires experience to determine whether special components need to be added to liquefy / dilute the sample. Complex components may affect molecular detection. In the present invention, PBS buffer is added for treatment.

[0020] Wherein, in step (1), the PBS buffer is: a PBS buffer with a pH of 7.4.

[0021] Specifically, the PBS buffer solution is prepared by adding 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, and 0.24 g KH2PO4 to 1000 mL distilled water, and adjusting the pH to 7.4 with HCl.

[0022] The special cell wall morphology of mycobacteria is a key factor affecting the extraction efficiency. In the present invention, a combination of zirconium oxide beads with different particle sizes is used to break the cell wall of mycobacteria.

[0023] Wherein, in step (2), the grinding is performed using grinding beads; the grinding beads are zirconia beads with a diameter of 0.1 to 3 mm.

[0024] Specifically, the grinding beads include 0.5 g of 3 mm zirconia beads, 0.5 g of 1 mm zirconia beads, and 0.25 g of 0.1 mm zirconia beads.

[0025] Wherein, in step (2), the protease is proteinase K, and its concentration is 10-20 mg / mL, preferably 20 mg / mL.

[0026] Wherein, in step (2), the first incubation is carried out under the following incubation conditions: incubation at 55-58° C. for 8-12 min.

[0027] Lysis is another major factor affecting the efficiency of nucleic acid extraction from pathogenic mycobacteria. Two extraction methods are provided in the present invention.

[0028] Among them, extraction method 1 is: grinding → protein decomposition → cleavage → binding → washing → elution; extraction method 2 is: grinding → protein decomposition → cleavage binding → washing → elution.

[0029] Wherein, in step (3), the lysate comprises the following components: 0.4-0.6 g / L guanidine thiocyanate, 0.003-0.005 g / L sodium acetate, 0.006-0.008 g / L sodium chloride, and 0.01-0.015 g / L sodium dodecyl sulfate.

[0030] Preferably, the lysate comprises the following components: 0.5 g / L guanidine thiocyanate, 0.004 g / L sodium acetate, 0.007 g / L sodium chloride, and 0.01 g / L sodium dodecyl sulfate.

[0031] Wherein, in step (3), when the lysis and binding are performed separately, the specific steps are: adding the lysis solution to the mixed solution after the first incubation obtained in step (2), mixing and performing a second incubation to obtain a mixed solution; then centrifuging the mixed solution to obtain the supernatant, adding the magnetic bead suspension and the binding solution, mixing and centrifuging, and removing the supernatant to obtain magnetic beads with mycobacterial nucleic acid adsorbed on the surface; when the lysis and binding are performed together, the specific steps are: at room temperature, adding the lysis solution, the magnetic bead suspension and the binding solution to the mixed solution after the first incubation obtained in step (2) in sequence, and continuously vortexing and mixing for 3 to 5 minutes.

[0032] Preferably, the second incubation is carried out under the following conditions: incubation at 65-70° C. for 8-12 min.

[0033] Wherein, in step (3), the binding liquid is isopropanol.

[0034] Wherein, in step (4), the first washing solution comprises the following components: 0.8-1.2 mol / L Tris-HCl, pH 8.0, 0.35-0.5 g / L guanidine hydrochloride, and 78-82% by volume of anhydrous ethanol; the second washing solution comprises the following components: 78-82% by volume of anhydrous ethanol and 18-22% by volume of ddH2O.

[0035] Wherein, in step (5), the eluent comprises the following components: 9.5-10.5 mmol / L Tris-HCl, pH 8.0, 1-1.2 mmol / L EDTA; and the incubation conditions are room temperature incubation for 5-10 min.

[0036] Beneficial effects:

[0037] (1) The present invention establishes a method for extracting mycobacterial nucleic acid from sputum samples or bronchoalveolar lavage fluid samples. For the detection of clinical samples, this method can meet the requirements of molecular detection extraction performance and can effectively reduce the detection cost and operation complexity.

[0038] (2) Compared with selecting components containing NaOH or dithiothreitol (DTT) for sputum liquefaction, the present invention uses PBS buffer for liquefaction and dilution treatment, which avoids the use of toxic reagents and reduces reagent costs. The operation is simple and the risk of automated adaptation of reagent characteristics is low. In addition, the amount of PBS buffer added does not affect the detection, and the added ratio can easily form a standard operating plan.

[0039] (3) The present invention adopts a combination of zirconium oxide beads of different particle sizes to form an efficient wall-breaking system, and combined with a mechanical procedure, it can effectively complete the wall-breaking treatment of mycobacteria, improve the grinding efficiency, and shorten the grinding time.

[0040] (4) The present invention can be combined after high-temperature lysis incubation and cooling, thereby improving the extraction efficiency. It can also achieve good lysis and extraction effects at room temperature, avoiding the influence of high-temperature lysis on the extraction time and aerosol. At the same time, it can meet the synchronization of lysis and combination, without the need for separate lysis and combination operations, and has no special requirements for the instrument module in the automated adaptation process.

[0041] (5) The nucleic acid binding efficiency of the present invention is high and it is easy to adapt to instrument automation. Compared with mature commercial kits, the extraction efficiency of mycobacterial nucleic acid is higher and the detection results are more stable. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments, and the above and / or other advantages of the present invention will become more clear.

[0043] Figure 1 The flowchart of the method 1 for extracting nucleic acid from mycobacteria of the present invention is shown in FIG.

[0044] Figure 2 This is a flow chart of the Mycobacterium nucleic acid extraction method 2 of the present invention.

[0045] Figure 3 Linear analysis graph for mycobacterium detection. DETAILED DESCRIPTION

[0046] The experimental methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials described are commercially available unless otherwise specified.

[0047] In the following examples, the consumables and reagents used in the mycobacterium extraction process of sputum samples are shown in Table 1.

[0048] Table 1 Consumables and reagents used in the mycobacterial extraction process of sputum samples

[0049]

[0050] Example 1: Feasibility analysis of combined use of lysis buffer and binding buffer

[0051] 1. Preparation of samples to be tested: Escherichia coli and Staphylococcus aureus inactivated bacteria quality control products (Escherichia coli purchased from Universal Biological, Catalog No.: CDX062; Staphylococcus aureus purchased from Beina Biological, Catalog No.: BNCC374293) were gradiently diluted to 1000 copies / μL, and Escherichia coli and Staphylococcus aureus were added to 400 μL anticoagulated rabbit blood (purchased from Wuhan Pure Biological, Catalog No.: CDX062) as the samples to be tested, with a theoretical input of 1000 copies (0.8-1.2 μL);

[0052] 2. Extraction process: divided into lysis and combination separate extraction process 1( Figure 1 ), wherein high temperature incubation is required for lysis; lysis combined with extraction process 2 ( Figure 2 ), wherein the cleavage and binding are at room temperature.

[0053] Extraction process 1: grinding → protein decomposition → lysis → binding → washing → elution.

[0054] 2.1 Sample pretreatment: Add the sample to be tested and 100 μL sample release agent (Nanjing Puji Biotechnology, Catalog No.: PJ204041) into a grinding tube, shake and mix well, then grind with grinding beads, and take the supernatant into a clean EP tube for extraction.

[0055] 2.2 Add 400 μL of the supernatant obtained in step 2.1 to a 1.5 mL centrifuge tube, add 40 μL of 20 mg / mL proteinase K, vortex mix for 10 seconds, and incubate at 56°C for 10 minutes.

[0056] 2.3 Lysis: Add 600 μL of lysis solution to the mixture obtained after incubation in step 2.2, vortex mix for 30 seconds, and incubate at 70°C for 10 minutes.

[0057] 2.4 Binding: Add 20 μL of magnetic bead suspension and 400 μL of binding solution to the lysate obtained after incubation in step 2.3, and vortex for 3 minutes. Note: Magnetic beads need to be vortexed before use to ensure that the beads are thoroughly resuspended.

[0058] 2.5 Place the centrifuge tube on the magnetic rack and let it stand for 2 minutes. Wait for the magnetic beads to be completely adsorbed, and carefully discard the liquid. Add 700 μL of the first washing solution, vortex and mix for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. Wait for the magnetic beads to be completely adsorbed, and carefully discard the liquid.

[0059] 2.6 Add 700 μL of the second washing solution and vortex for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid.

[0060] 2.7 To ensure that the residual liquid is sucked out as much as possible, the centrifuge tube can be quickly centrifuged for 10 seconds, and then placed on a magnetic stand and aspirated with a 10μL pipette. Open the tube cap and place it at room temperature for 5 to 10 minutes until the ethanol is completely evaporated and the surface of the magnetic beads is non-reflective or just cracked.

[0061] 2.8 Remove the centrifuge tube from the magnetic rack, add 50 μL of elution solution, vortex for 30 seconds to fully dissolve the magnetic beads in the elution solution, and incubate at room temperature for 5 to 10 minutes. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for about 2 minutes. After the magnetic beads are completely adsorbed, carefully pipette the supernatant into a new centrifuge tube to obtain the nucleic acid extraction product.

[0062] Extraction process 2: Grinding → protein decomposition → cleavage and binding → washing → elution

[0063] Combine the lysis in step 2.3 and step 2.4 in extraction process 1. The specific operation steps are as follows: at room temperature, add 600 μL of lysis solution, 20 μL of magnetic bead suspension and 400 μL of binding solution to the mixed solution obtained after incubation in step 2.2, and continue vortexing for 3 to 5 minutes. The remaining steps are the same as extraction process 1.

[0064] (3) Extraction result verification method: Digital PCR was used for quantitative analysis to evaluate the extraction efficiency. The specific experimental steps are as follows:

[0065] 3.1 Prepare digital PCR reaction system: The PCR reaction system includes 5 μL DNA template (supernatant aspirated in step 2.8), 11.25 μL 4*ppmix containing primer probe combination, 22.5 μL 2* premix containing reaction substrate and polymerase, and ddH2O is added to 45 μL.

[0066] Among them, the primers and probes used for digital PCR detection of target sequences are shown in Table 2 below.

[0067] Table 2 Primers and probes used for digital PCR detection of target sequences

[0068]

[0069] 3.2 Add 45 μL of PCR reaction system and 110 μL of droplet generation oil to the droplet generation chip, place the droplet generation chip in a sample preparation instrument (Nanjing Puji Biotechnology BMDG-50W) for droplet generation; after the droplet generation is completed, transfer the droplets to the PCR plate and seal the film.

[0070] 3.3 Perform digital PCR amplification on the PCR plate in a thermal amplification instrument (Nanjing Puji Biotechnology BMCV96-BV).

[0071] 3.4 After the PCR amplification reaction is completed, the PCR plate is placed in a reader (Nanjing Puji Biotechnology PJYD-6800) for droplet detection, and the copy number of the target gene amplified by the primer and probe combination is determined based on the detection results.

[0072] 3.5 The copy number information of the fragments to be tested in the sample was analyzed according to the test results. The results of the extraction efficiency analysis of Staphylococcus aureus (S.aur) and Escherichia coli (E.coli) are shown in Table 3 below. From the results, it can be seen that the copy number of Escherichia coli and Staphylococcus aureus extracted by the extraction process 1, which is separated from the lysis and binding and incubated at high temperature during lysis, and the lysis and binding at room temperature in the extraction process 2, is not significantly different (t test, P>0.1). This shows that the incubation of the lysis solution at room temperature and high temperature, as well as the combined use of the lysis solution and the binding solution, have little effect on the extraction efficiency of the sample to be tested.

[0073] Table 3 Detection results of different extraction steps

[0074]

[0075] Example 2 Mycobacterium Extraction from Sputum Samples

[0076] (1) Preparation of test samples: Prepare artificial simulated sputum. Take 1.5 mL EP tubes, add 100 μL of artificial simulated sputum to each tube, and add inactivated Mycobacterium tuberculosis and Mycobacterium avium quality control products with a total theoretical value of about 200 copies in proportion. Mix well and set aside as test samples.

[0077] Among them, the preparation process of artificial simulated sputum is as follows: dissolve 9g / L sodium chloride, 10g / L glucose, 15g / L alkyl glycoside, 10g / L β-cyclodextrin, and 2g / L hydroxypropyl β-cyclodextrin with a final concentration in 1L water according to proportion, mix evenly, and form artificial simulated sputum with a certain viscosity.

[0078] (2) Extraction process: sputum liquefaction → grinding → lysis → combination → washing → elution

[0079] 2.1 Sputum liquefaction: PBS buffer (pH 7.4) was added to the sample to be tested at a ratio of 1:1 to 1:4, and mixed by pipetting. In principle, the thicker the sputum, the more PBS buffer was added. In this example, 200 μL PBS buffer was added to 100 μL of the sample to be tested.

[0080] 2.2 Sample pretreatment: Add the sample to be tested after sputum liquefaction in step 2.1 and 100 μL sample release agent (Nanjing Puji Biological, catalog number: PJ204041) into the grinding tube, shake and mix well, then grind with grinding beads, and take the supernatant into a clean EP tube for extraction.

[0081] 2.3 Take 400 μL of the supernatant obtained in step 2.2, add it to a 1.5 mL centrifuge tube, add 40 μL of 20 mg / mL proteinase K, vortex mix for 10 seconds, and incubate at 56°C for 10 minutes.

[0082] 2.4 Lysis: Add 600 μL lysis buffer, vortex mix for 30 seconds, and incubate at 70°C for 10 minutes.

[0083] 2.5 Binding: Add 20 μL magnetic bead suspension and 400 μL binding solution, and vortex for 3 minutes. Note: Magnetic beads need to be vortexed before use to ensure that the beads are thoroughly resuspended.

[0084] 2.6 Place the centrifuge tube in step 2.5 on the magnetic rack and let it stand for 2 minutes. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid. Add 700 μL of the first washing solution and vortex for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid.

[0085] 2.7 Add 700 μL of the second washing solution and vortex for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid.

[0086] 2.8 To ensure that the residual liquid is sucked out as much as possible, the centrifuge tube can be quickly centrifuged for 10 seconds, and then placed on a magnetic stand and aspirated with a 10μL pipette. Open the tube cover and place it at room temperature for 5 to 10 minutes until the ethanol is completely evaporated and the surface of the magnetic beads is non-reflective or just cracked.

[0087] 2.9 Remove the centrifuge tube from the magnetic rack, add 50 μL of elution solution, vortex for 30 seconds to fully dissolve the magnetic beads in the elution solution, and incubate at room temperature for 5 to 10 minutes. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for about 2 minutes. After the magnetic beads are completely adsorbed, carefully pipette the supernatant into a new centrifuge tube to obtain the mycobacterial nucleic acid in the sputum sample.

[0088] (3) Extraction result verification method: Digital PCR was used for quantitative analysis to evaluate the extraction efficiency, and an imported commercial kit (QIAamp UCP Pathogen Mini Kit) was used for comparison.

[0089] The experimental steps are as follows:

[0090] 3.1 Prepare digital PCR reaction system: The PCR reaction system includes 5 μL DNA template (supernatant aspirated in step 2.9), 11.25 μL 4*ppmix containing primer probe combination, 22.5 μL 2* premix containing reaction substrate and polymerase, and ddH2O is added to 45 μL.

[0091] Among them, the primers and probes used for digital PCR detection of target sequences are shown in Table 4 below.

[0092] Table 4 Primers and probes used for digital PCR detection of target sequences

[0093]

[0094] 3.2 Add 45 μL of PCR reaction system and 110 μL of droplet generation oil to the droplet generation chip, place the droplet generation chip in a sample preparation instrument (Nanjing Puji Biotechnology BMDG-50W) for droplet generation; after the droplet generation is completed, transfer the droplets to the PCR plate and seal the film.

[0095] 3.3 Perform digital PCR amplification on the PCR plate in a thermal amplification instrument (Nanjing Puji Biotechnology BMCV96-BV).

[0096] 3.4 After the PCR amplification reaction is completed, the PCR plate is placed in a reader (Nanjing Puji Biotechnology PJYD-6800) for droplet detection, and the copy number of the target gene amplified by the primer and probe combination is determined based on the detection results.

[0097] 3.5 The copy number information of the fragment to be tested in the sample was analyzed according to the test results. The results are shown in Table 5.

[0098] Table 5 Analysis of mycobacterium extraction results of sputum samples

[0099]

[0100] As can be seen from Table 5, the experiment was repeated 3 times in total. In each 5 μL sample volume, the average copy number of the fragment to be tested in the sample detected by the digital PCR of the present invention was about 11.65 copies, while the average copy number obtained by the commercial universal kit was about 7.51 copies. This shows that the mycobacterium nucleic acid extraction method of the present invention can effectively extract mycobacterium nucleic acid, and the extraction efficiency is higher than that of the commercial universal kit, but the stability (CV) of the extraction efficiency is slightly worse.

[0101] Example 3 Mycobacterium Extraction from Bronchoalveolar Lavage Fluid Samples

[0102] (1) Preparation of test samples: Add approximately 200 copies of inactivated Mycobacterium tuberculosis and Mycobacterium avium quality control products to 100 μL of simulated alveolar lavage fluid sample (purchased from Maokang Biotechnology), mix well and set aside as the test sample.

[0103] (2) Extraction process: dilution → grinding → lysis → binding → washing → elution

[0104] 2.1 Dilution of alveolar lavage fluid: Add PBS buffer (pH 7.4) to the sample to be tested at a ratio of 2:1 to 1:1, and mix well by pipetting. In principle, the clearer the alveolar lavage fluid, the less PBS buffer should be added, or even no PBS buffer should be added. In this example, 100 μL PBS buffer was added to 200 μL of the sample to be tested.

[0105] 2.2 Sample pretreatment: Add the sample to be tested in step 2.1 and 100 μL sample release agent (Nanjing Puji Biological, catalog number: PJ204041) into the grinding tube, shake and mix well, grind with grinding beads, and take the supernatant into a clean EP tube for extraction.

[0106] 2.3 Take 400 μL of the above supernatant, add it to a 1.5 mL centrifuge tube, add 40 μL of 20 mg / mL proteinase K, vortex mix for 10 seconds, and incubate at 56°C for 10 minutes.

[0107] 2.4 Lysis: Add 600 μL lysis buffer, vortex mix for 30 seconds, and incubate at 70°C for 10 minutes.

[0108] 2.5 Binding: Add 20 μL magnetic bead suspension and 400 μL binding solution, and vortex for 3 minutes. Note: Magnetic beads need to be vortexed before use to ensure that the beads are thoroughly resuspended.

[0109] 2.6 Place the centrifuge tube in step 2.5 on the magnetic rack and let it stand for 2 minutes. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid. Add 700 μL of the first washing solution and vortex for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid.

[0110] 2.7 Add 700 μL of the second washing solution and vortex for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid.

[0111] 2.8 To ensure that the residual liquid is sucked out as much as possible, the centrifuge tube can be quickly centrifuged for 10 seconds, and then placed on a magnetic stand and aspirated with a 10μL pipette. Open the tube cover and place it at room temperature for 5 to 10 minutes until the ethanol is completely evaporated and the surface of the magnetic beads is non-reflective or just cracked.

[0112] 2.9 Remove the centrifuge tube from the magnetic rack, add 50 μL of elution solution, vortex for 30 seconds to fully dissolve the magnetic beads in the elution solution, and incubate at room temperature for 5 to 10 minutes. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for about 2 minutes. After the magnetic beads are completely adsorbed, carefully pipette the supernatant into a new centrifuge tube to obtain the mycobacterial nucleic acid in the alveolar lavage fluid sample.

[0113] (3) Extraction result verification method: Digital PCR quantitative analysis was used to evaluate the extraction efficiency, and an imported commercial kit (QIAamp UCP Pathogen Mini Kit) was used for comparison.

[0114] The experimental steps are as follows:

[0115] 3.1 Prepare PCR reaction system: The PCR reaction system includes 5 μL DNA template (supernatant aspirated in step 2.9), 11.25 μL 4*ppmix containing primer-probe combination, 22.5 μL 2* premix containing reaction substrate and polymerase, and ddH2O is added to 45 μL. The primers and probes used for digital PCR detection of target sequences are the same as those in Table 5.

[0116] 3.2 Add 45 μL of PCR reaction system and 110 μL of droplet generation oil to the droplet generation chip, place the droplet generation chip in a sample preparation instrument (Nanjing Puji Biotechnology BMDG-50W) for droplet generation; after the droplet generation is completed, transfer the droplets to the PCR plate and seal the film.

[0117] 3.3 Perform digital PCR amplification on the PCR plate in a thermal amplification instrument (Nanjing Puji Biotechnology BMCV96-BV).

[0118] 3.4 After the PCR amplification reaction is completed, the PCR plate is placed in a reader (Nanjing Puji Biotechnology PJYD-6800) for droplet detection, and the copies of the target gene amplified by the primer combination are determined based on the detection results.

[0119] 3.5 The copy number information of the fragment to be tested in the sample was analyzed according to the test results. The results are shown in Table 6.

[0120] Table 6 Analysis of mycobacterial extraction results of bronchoalveolar lavage fluid samples

[0121]

[0122] As can be seen from Table 6, the experiment was repeated 3 times in total. In each 5 μL sample volume, the average copy number of the fragment to be tested in the sample detected by the digital PCR of the present invention was about 14.86 copies, while the average copy number obtained by the commercial universal kit was about 11.19 copies. This shows that the mycobacterium nucleic acid extraction method of the present invention can effectively extract mycobacterium nucleic acid, and the extraction efficiency is higher than that of the commercial universal kit, and the stability (CV) of the extraction efficiency is consistent.

[0123] Example 4: Feasibility analysis of high-sensitivity detection technology for Mycobacterium tuberculosis

[0124] (1) Preparation of test samples: Add approximately 25, 50, 100, and 200 copies of inactivated Mycobacterium tuberculosis and Mycobacterium avium quality control products to 100 μL of simulated alveolar lavage fluid sample (purchased from Maokang Biotechnology), respectively, mix well, and use as test samples.

[0125] (2) Extraction process: dilution → grinding → lysis + binding → washing → elution

[0126] 2.1 Dilution of alveolar lavage fluid: Add PBS buffer (pH 7.4) to the sample to be tested at a ratio of 2:1 to 1:1, and mix well by pipetting. In principle, the clearer the alveolar lavage fluid, the less PBS buffer should be added, or even no PBS buffer should be added. In this example, 100 μL PBS buffer was added to 200 μL of the sample to be tested.

[0127] 2.2 Sample pretreatment: Add the sample to be tested in step 2.1 and 100 μL sample release agent (Nanjing Puji Biological, catalog number: PJ204041) into the grinding tube, shake and mix well, grind with grinding beads, and take the supernatant into a clean EP tube for extraction.

[0128] 2.3 Add 400 μL of the above supernatant to a 1.5 mL centrifuge tube, add 40 μL of 20 mg / mL proteinase K, vortex mix for 10 seconds, and incubate at 56°C for 10 minutes.

[0129] 2.4 Lysis and binding: Add 600 μL lysis solution, 20 μL magnetic bead suspension and 400 μL binding solution, and continue vortexing to mix for 3 to 5 minutes.

[0130] 2.5 Place the centrifuge tube in step 2.5 on the magnetic rack and let it stand for 2 minutes. Wait for the magnetic beads to be completely adsorbed, and carefully discard the liquid. Add 700 μL of the first washing solution, vortex and mix for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. Wait for the magnetic beads to be completely adsorbed, and carefully discard the liquid.

[0131] 2.6 Add 700 μL of the second washing solution and vortex for 1 minute to ensure that the magnetic beads are dispersed and there are no aggregated magnetic beads on the wall of the centrifuge tube. After a short centrifugation, place the centrifuge tube on the magnetic rack and let it stand for 1 minute. When the magnetic beads are completely adsorbed, carefully aspirate and discard the liquid.

[0132] 2.7 To ensure that the residual liquid is sucked out as much as possible, the centrifuge tube can be quickly centrifuged for 10 seconds, and then placed on a magnetic stand and aspirated with a 10μL pipette. Open the tube cap and place it at room temperature for 5 to 10 minutes until the ethanol is completely evaporated and the surface of the magnetic beads is non-reflective or just cracked.

[0133] 2.8 Remove the centrifuge tube from the magnetic rack, add 50 μL of elution solution, vortex for 30 seconds to fully dissolve the magnetic beads in the elution solution, centrifuge briefly, and incubate at room temperature for 5 to 10 minutes. After a brief centrifugation, place the centrifuge tube on the magnetic rack and let it stand for about 2 minutes. After the magnetic beads are completely adsorbed, carefully pipette the supernatant into a new centrifuge tube to obtain mycobacterial nucleic acid in the alveolar lavage fluid sample.

[0134] (3) Extraction result verification method: Digital PCR quantitative analysis was used to evaluate the extraction efficiency.

[0135] The experimental steps are as follows:

[0136] 3.1 Prepare PCR reaction system: The PCR reaction system includes 5 μL DNA template (supernatant aspirated in step 2.9), 11.25 μL 4*ppmix containing primer-probe combination, 22.5 μL 2* premix containing reaction substrate and polymerase, and ddH2O is added to 45 μL. The primers and probes used for digital PCR detection of target sequences are the same as those in Table 5.

[0137] 3.2 Add 45 μL of PCR reaction system and 110 μL of droplet generation oil to the droplet generation chip, place the droplet generation chip in a sample preparation instrument (Nanjing Puji Biotechnology BMDG-50W) for droplet generation; after the droplet generation is completed, transfer the droplets to the PCR plate and seal the film.

[0138] 3.3 Perform digital PCR amplification on the PCR plate in a thermal amplification instrument (Nanjing Puji Biotechnology BMCV96-BV).

[0139] 3.4 After the PCR amplification reaction is completed, the PCR plate is placed in a reader (Nanjing Puji Biotechnology PJYD-6800) for droplet detection, and the copy number of the target gene amplified by the primer combination is determined based on the detection results.

[0140] 3.5 Analyze the copy number of the fragment to be tested in the sample according to the test results. The results are shown in Table 7 and Figure 3 shown.

[0141] Table 7 Minimum detection limit (LoD) and linear analysis of mycobacterium detection (unit: copies)

[0142]

[0143] The above results show that bacterial content as low as 25 copies can be effectively detected, and the gradient dilution detection of mycobacteria, including Mycobacterium tuberculosis and Mycobacterium avium, has a good linear fit. This method meets the requirements for mycobacterium extraction and detection in low-concentration samples.

[0144] The present invention provides a method and idea for extracting mycobacteria. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the protection scope of the present invention. All components not specified in this embodiment can be implemented by existing technologies.

Claims

1. A method for extracting mycobacterial nucleic acid, characterized in that: The steps include: (1) Liquefaction and dilution: Add PBS buffer to the sample to be extracted and mix well to obtain a liquefied and diluted sample to be extracted; (2) grinding and incubation: the sample to be extracted after liquefaction and dilution in step (1) is mixed with the sample release agent and then ground, the supernatant is taken, protease is added, and the mixture is mixed and incubated for the first time to obtain a mixed solution; (3) Lysis and binding: adding the lysis solution, magnetic bead suspension and binding solution to the mixed solution after the first incubation obtained in step (2), mixing and centrifuging, and removing the supernatant to obtain magnetic beads with mycobacterial nucleic acid adsorbed on the surface; (4) Washing: adding a first washing solution to the magnetic beads of step (3), mixing and centrifuging, and removing the supernatant; then adding a second washing solution, mixing and centrifuging, and removing the supernatant to obtain magnetic beads with impurities removed and mycobacterial nucleic acid adsorbed on the surface; (5) Elution: resuspend the magnetic beads in step (4) using the elution solution, incubate, and centrifuge to obtain mycobacterial nucleic acid.

2. The extraction method according to claim 1, characterized in that The sample to be extracted is a sputum sample or a bronchoalveolar lavage fluid sample; the volume ratio of the sample to be extracted, PBS buffer, sample release agent and lysis solution is: 1-2:1-4:0.5-1:3-6.

3. The extraction method according to claim 1, characterized in that In step (1), the PBS buffer is a PBS buffer with a pH of 7.

4.

4. The extraction method according to claim 1, characterized in that In step (2), the grinding is performed using grinding beads; the grinding beads are zirconia beads with a diameter of 0.1 to 3 mm; the protease is proteinase K, and its concentration is 10 to 20 mg / mL; the first incubation is performed at 55 to 58° C. for 8 to 12 minutes.

5. The extraction method according to claim 1, characterized in that In step (3), the lysate comprises the following components: 0.4-0.6 g / L guanidine thiocyanate, 0.003-0.005 g / L sodium acetate, 0.006-0.008 g / L sodium chloride, and 0.01-0.015 g / L sodium dodecyl sulfate.

6. The extraction method according to claim 1, characterized in that In step (3), when the lysis and binding are performed separately, the specific steps are as follows: adding the lysis solution to the mixed solution after the first incubation obtained in step (2), mixing and performing a second incubation to obtain a mixed solution; then centrifuging the mixed solution to obtain the supernatant, adding the magnetic bead suspension and the binding solution, mixing and centrifuging, and removing the supernatant to obtain magnetic beads with mycobacterial nucleic acid adsorbed on the surface; when the lysis and binding are performed together, the specific steps are as follows: at room temperature, adding the lysis solution, the magnetic bead suspension and the binding solution to the mixed solution after the first incubation obtained in step (2) in sequence, and continuously vortexing and mixing for 3 to 5 minutes.

7. The extraction method according to claim 6, characterized in that The second incubation is carried out under the following conditions: incubation at 65-70° C. for 8-12 minutes.

8. The extraction method according to claim 1, characterized in that In step (3), the binding liquid is isopropanol.

9. The extraction method according to claim 1, characterized in that In step (4), the first washing solution comprises the following components: 0.8-1.2 mol / L Tris-HCl, pH 8.0, 0.35-0.5 g / L guanidine hydrochloride, and 78-82% by volume of anhydrous ethanol; the second washing solution comprises the following components: 78-82% by volume of anhydrous ethanol and 18-22% by volume of ddH2O.

10. The extraction method according to claim 1, characterized in that In step (5), the eluent comprises the following components: 9.5-10.5 mmol / L Tris-HCl, pH 8.0, and 1-1.2 mmol / L EDTA; and the incubation is carried out at room temperature for 5-10 minutes.